Global Sleep Apnea Devices Market Size By Product (Diagnostic Devices Therapeutic Devices), By End-use (Sleep Laboratories, Hospitals) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-214 | Category : Medical Devices | Published Date : July, 2019 | Pages : 402 | Format :PDF
Buy Now!

Industry Trends

Global sleep apnea devices market was valued at US$ 4,120 in 2018 and is estimated to reach US$ 9,510 million by 2027, growing at a CAGR of 9.7% over the forecast period.

Global Sleep Apnea Devices Market Revenue, 2019 - 2027

Global sleep apnea devices market

Globally, increasing awareness of sleep apnea is the primary reason behind sleep apnea devices market growth. Untreated symptoms of this disorder lead to decreased overall health, and life-threatening complications; making it one of the top health issues for healthcare providers around the globe. According to National Sleep Foundation more than 18 million Americans are affected by sleep apnea. In addition, excessive consumption of alcohol and smoking are also regarded as crucial reasons behind development of sleep apnea complications. According to National Sleep Foundation, although sleep apnea is common among adults over 40 years of age and above, its prevalence is also common among people from all age groups; resulting in broad patient pool to cater to. Furthermore, umpteen manufacturers for positive airway pressure therapy (PAP) are offering variety of machines with different features and targeting different patient age group.

From the demand side of the market, home-based sleep apnea tests are becoming a major market growth rendering factor. Home-based sleep tests induce increased comfort of patients and also fosters low-cost therapy, which is ultimately a factor that will drive the market for sleep apnea devices market expansion.

Though there is huge need for sleep apnea devices, factors such as high cost pertaining to CPAP devices will hinder sleep apnea devices market expansion. Moreover, negligence about respiratory problems from un-diagnosed patients, especially in resource poor economies also happens to be a market expansion constraining factor.

Sleep apnea devices consists of two major product categories, namely diagnostic devices and therapeutic devices. Diagnostic sleep apnea devices held larger market share than therapeutic devices and are estimated to follow the same trend over the forecast period. Demand for early diagnosis of respiratory disorders is the major factor that is augmenting diagnostic sleep apnea devices market growth.

According to American Sleep Apnea Association, continuous positive airway pressure therapy (CPAP) is the most commonly used and the very first form of therapy to treat patients with obstructive sleep apnea, especially in its most severe form-25. This attributes to the well-established market for CPAP devices.

North American sleep apnea devices market is estimated to witness robust growth over the forecast period, owing to upgraded and affordable advancements in the therapeutic devices. Continuous upgradation by device manufacturing companies offer various choice for PAP therapy to patients and healthcare providers. Productive efforts by organizations such as the Sleepapnea’s CPAP Assistance Program (CAP) which has provided over 7,500 CPAP equipment packages to patients over the last three years, are driving the demand for various sleep apnea devices. However, lack of insurance coverage on sophisticated machines proves to be growth arresting factor.

The report provides both, qualitative and quantitative research of sleep apnea devices market, it also provides penetrative insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in the market and detailed insights into the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by major players are also recognized and analyzed in the report. For each company, the report recognizes its headquarters, competitors, product/service type, application and specification, pricing, and gross margin.

Competitive Landscape

Some of the major industry participants in the global sleep apnea devices market include Fisher & Paykel Healthcare Limited, Invacare Corporation, Phillips Respironics, Compumedics Limited, Cadwell Laboratories, ResMed, BMC Medical Co. Ltd, Braebon Medical Corporation, Nihon Kohden, and ImThera Medical Inc.

By Product

  • Therapeutic Devices
    • Positive Airway Pressure (PAP) device
      • Bi-level positive airway pressure (BiPAP) device
      • Continuous positive airway pressure (CPAP) device
      • Automatic positive airway pressure (APAP) device
    • Airway clearance systems
    • Adaptive servo-ventilation systems
    • Oral appliances
    • Oxygen devices
    • Masks
      • Full face masks
      • Nasal masks
      • Nasal pillows
      • Nasal prongs
      • Oral masks
    • Tubes
    • Humidifiers
    • Filters
  • Diagnostic Devices
    • Actigraphy systems
    • Polysomnography (PSG) device
    • Respiratory polygraphs
  • Pulse oximeters

By End User

  • Sleep laboratories
  • Hospitals
  • Home care centers
  • Individuals
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
    • Benelux Union
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • New Zealand
    • Australia
    • South Korea
    • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
    • Rest of Asia Pacific
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Argentina
    • Brazil
    • Rest of Latin America

Key Questions

Request Sample

Report Customization

Request for Customization

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2013 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Sleep Apnea Devices Market

6.    Market Synopsis:  Sleep Apnea Devices Market

7.    Sleep Apnea Devices Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Sleep Apnea Devices Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Sleep Apnea Devices Market

7.6. Industry Gross Margin Overview

7.7. Porter’s Five Force Analysis

8.    Global Sleep Apnea Devices Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global Sleep Apnea Devices Market Revenue (US$ Mn)

8.2. Global Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.2.1. Therapeutic Devices (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Positive Airway Pressure (PAP) device, Airway clearance systems, Adaptive servo-ventilation systems, Oral appliances, Oxygen devices, Masks, Tubes, Humidifiers, Filters)

8.2.1.1. Positive Airway Pressure (PAP) device

8.2.1.1.1.    Bi-level positive airway pressure (BiPAP) device

8.2.1.1.2.    Continuous positive airway pressure (CPAP) device

8.2.1.1.3.    Automatic positive airway pressure (APAP) device

8.2.1.2. Airway clearance systems

8.2.1.3. Adaptive servo-ventilation systems

8.2.1.4. Oral appliances

8.2.1.5. Oxygen devices

8.2.1.6. Masks

8.2.1.6.1.    Full face masks

8.2.1.6.2.    Nasal masks

8.2.1.6.3.    Nasal pillows

8.2.1.6.4.    Nasal prongs

8.2.1.6.5.    Oral masks

8.2.1.7. Tubes

8.2.1.8. Humidifiers

8.2.1.9. Filters

8.2.2. Diagnostic Devices (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Actigraphy systems, Polysomnography (PSG) device, Respiratory polygraphs, Pulse oximeters)

8.2.2.1. Actigraphy systems

8.2.2.2. Polysomnography (PSG) device

8.2.2.3. Respiratory polygraphs

8.2.2.4. Pulse oximeters

8.3. Key Segment for Channeling Investments

8.3.1. By Product

9.    Global Sleep Apnea Devices Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.2.1. Hospitals

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2013 – 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1.    North America

9.2.1.6.1.1. Market Estimation, 2013 – 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2.    Europe

9.2.1.6.2.1. Market Estimation, 2013 – 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3.    Asia Pacific

9.2.1.6.3.1. Market Estimation, 2013 – 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4.    Middle East and Africa

9.2.1.6.4.1. Market Estimation, 2013 – 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.1.6.5.    Latin America

9.2.1.6.5.1. Market Estimation, 2013 – 2018

9.2.1.6.5.2. Market Forecast, 2019 – 2027

9.2.2. Sleep laboratories

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2013 – 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1.    North America

9.2.2.6.1.1. Market Estimation, 2013 – 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2.    Europe

9.2.2.6.2.1. Market Estimation, 2013 – 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3.    Asia Pacific

9.2.2.6.3.1. Market Estimation, 2013 – 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4.    Middle East and Africa

9.2.2.6.4.1. Market Estimation, 2013 – 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.2.6.5.    Latin America

9.2.2.6.5.1. Market Estimation, 2013 – 2018

9.2.2.6.5.2. Market Forecast, 2019 – 2027

9.2.3. Home care settings

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2013 – 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1.    North America

9.2.3.6.1.1. Market Estimation, 2013 – 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2.    Europe

9.2.3.6.2.1. Market Estimation, 2013 – 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3.    Asia Pacific

9.2.3.6.3.1. Market Estimation, 2013 – 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4.    Middle East and Africa

9.2.3.6.4.1. Market Estimation, 2013 – 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.2.3.6.5.    Latin America

9.2.3.6.5.1. Market Estimation, 2013 – 2018

9.2.3.6.5.2. Market Forecast, 2019 – 2027

9.2.4. Individuals

9.2.4.1. Definition

9.2.4.2. Market Penetration, 2018

9.2.4.3. Market Estimation, 2013 – 2018

9.2.4.4. Market Forecast, 2019 – 2027

9.2.4.5. Compound Annual Growth Rate (CAGR)

9.2.4.6. Regional Bifurcation

9.2.4.6.1.    North America

9.2.4.6.1.1. Market Estimation, 2013 – 2018

9.2.4.6.1.2. Market Forecast, 2019 – 2027

9.2.4.6.2.    Europe

9.2.4.6.2.1. Market Estimation, 2013 – 2018

9.2.4.6.2.2. Market Forecast, 2019 – 2027

9.2.4.6.3.    Asia Pacific

9.2.4.6.3.1. Market Estimation, 2013 – 2018

9.2.4.6.3.2. Market Forecast, 2019 – 2027

9.2.4.6.4.    Middle East and Africa

9.2.4.6.4.1. Market Estimation, 2013 – 2018

9.2.4.6.4.2. Market Forecast, 2019 – 2027

9.2.4.6.5.    Latin America

9.2.4.6.5.1. Market Estimation, 2013 – 2018

9.2.4.6.5.2. Market Forecast, 2019 – 2027

9.2.5. Others

9.2.5.1. Definition

9.2.5.2. Market Penetration, 2018

9.2.5.3. Market Estimation, 2013 – 2018

9.2.5.4. Market Forecast, 2019 – 2027

9.2.5.5. Compound Annual Growth Rate (CAGR)

9.2.5.6. Regional Bifurcation

9.2.5.6.1.    North America

9.2.5.6.1.1. Market Estimation, 2013 – 2018

9.2.5.6.1.2. Market Forecast, 2019 – 2027

9.2.5.6.2.    Europe

9.2.5.6.2.1. Market Estimation, 2013 – 2018

9.2.5.6.2.2. Market Forecast, 2019 – 2027

9.2.5.6.3.    Asia Pacific

9.2.5.6.3.1. Market Estimation, 2013 – 2018

9.2.5.6.3.2. Market Forecast, 2019 – 2027

9.2.5.6.4.    Middle East and Africa

9.2.5.6.4.1. Market Estimation, 2013 – 2018

9.2.5.6.4.2. Market Forecast, 2019 – 2027

9.2.5.6.5.    Latin America

9.2.5.6.5.1. Market Estimation, 2013 – 2018

9.2.5.6.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By End User

10. North America Sleep Apnea Devices Market Analysis and Forecasts, 2019 - 2027

10.1. Overview

10.1.1. North America Sleep Apnea Devices Market Revenue (US$ Mn)

10.2. North America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.2.1. Therapeutic Devices

10.2.1.1. Positive Airway Pressure (PAP) device

10.2.1.1.1.  Bi-level positive airway pressure (BiPAP) device

10.2.1.1.2.  Continuous positive airway pressure (CPAP) device

10.2.1.1.3.  Automatic positive airway pressure (APAP) device

10.2.1.2. Airway clearance systems

10.2.1.3. Adaptive servo-ventilation systems

10.2.1.4. Oral appliances

10.2.1.5. Oxygen devices

10.2.1.6. Masks

10.2.1.6.1.  Full face masks

10.2.1.6.2.  Nasal masks

10.2.1.6.3.  Nasal pillows

10.2.1.6.4.  Nasal prongs

10.2.1.6.5.  Oral masks

10.2.1.7. Tubes

10.2.1.8. Humidifiers

10.2.1.9. Filters

10.2.2. Diagnostic Devices

10.2.2.1. Actigraphy systems

10.2.2.2. Polysomnography (PSG) device

10.2.2.3. Respiratory polygraphs

10.2.2.4. Pulse oximeters

10.3. North America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.3.1. Hospitals

10.3.2. Sleep laboratories

10.3.3. Home care settings

10.3.4. Individuals

10.3.5. Others

10.4. North America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. U.S

10.4.1.1. U.S Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.1.1.1.  Therapeutic Devices

10.4.1.1.1.1. Positive Airway Pressure (PAP) device

10.4.1.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

10.4.1.1.1.1.2.    Continuous positive airway pressure (CPAP) device

10.4.1.1.1.1.3.    Automatic positive airway pressure (APAP) device

10.4.1.1.1.2. Airway clearance systems

10.4.1.1.1.3. Adaptive servo-ventilation systems

10.4.1.1.1.4. Oral appliances

10.4.1.1.1.5. Oxygen devices

10.4.1.1.1.6. Masks

10.4.1.1.1.6.1.    Full face masks

10.4.1.1.1.6.2.    Nasal masks

10.4.1.1.1.6.3.    Nasal pillows

10.4.1.1.1.6.4.    Nasal prongs

10.4.1.1.1.6.5.    Oral masks

10.4.1.1.1.7. Tubes

10.4.1.1.1.8. Humidifiers

10.4.1.1.1.9. Filters

10.4.1.1.2.  Diagnostic Devices

10.4.1.1.2.1. Actigraphy systems

10.4.1.1.2.2. Polysomnography (PSG) device

10.4.1.1.2.3. Respiratory polygraphs

10.4.1.1.2.4. Pulse oximeters

10.4.1.2. U.S Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.1.2.1.  Hospitals

10.4.1.2.2.  Sleep laboratories

10.4.1.2.3.  Home care settings

10.4.1.2.4.  Individuals

10.4.1.2.5.  Others

10.4.2. Canada

10.4.2.1. Canada Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.2.1.1.  Therapeutic Devices

10.4.2.1.1.1. Positive Airway Pressure (PAP) device

10.4.2.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

10.4.2.1.1.1.2.    Continuous positive airway pressure (CPAP) device

10.4.2.1.1.1.3.    Automatic positive airway pressure (APAP) device

10.4.2.1.1.2. Airway clearance systems

10.4.2.1.1.3. Adaptive servo-ventilation systems

10.4.2.1.1.4. Oral appliances

10.4.2.1.1.5. Oxygen devices

10.4.2.1.1.6. Masks

10.4.2.1.1.6.1.    Full face masks

10.4.2.1.1.6.2.    Nasal masks

10.4.2.1.1.6.3.    Nasal pillows

10.4.2.1.1.6.4.    Nasal prongs

10.4.2.1.1.6.5.    Oral masks

10.4.2.1.1.7. Tubes

10.4.2.1.1.8. Humidifiers

10.4.2.1.1.9. Filters

10.4.2.1.2.  Diagnostic Devices

10.4.2.1.2.1. Actigraphy systems

10.4.2.1.2.2. Polysomnography (PSG) device

10.4.2.1.2.3. Respiratory polygraphs

10.4.2.1.2.4. Pulse oximeters

10.4.2.2. Canada Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.2.2.1.  Hospitals

10.4.2.2.2.  Sleep laboratories

10.4.2.2.3.  Home care settings

10.4.2.2.4.  Individuals

10.4.2.2.5.  Others

10.4.3. Mexico

10.4.3.1. Mexico Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.3.1.1.  Therapeutic Devices

10.4.3.1.1.1. Positive Airway Pressure (PAP) device

10.4.3.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

10.4.3.1.1.1.2.    Continuous positive airway pressure (CPAP) device

10.4.3.1.1.1.3.    Automatic positive airway pressure (APAP) device

10.4.3.1.1.2. Airway clearance systems

10.4.3.1.1.3. Adaptive servo-ventilation systems

10.4.3.1.1.4. Oral appliances

10.4.3.1.1.5. Oxygen devices

10.4.3.1.1.6. Masks

10.4.3.1.1.6.1.    Full face masks

10.4.3.1.1.6.2.    Nasal masks

10.4.3.1.1.6.3.    Nasal pillows

10.4.3.1.1.6.4.    Nasal prongs

10.4.3.1.1.6.5.    Oral masks

10.4.3.1.1.7. Tubes

10.4.3.1.1.8. Humidifiers

10.4.3.1.1.9. Filters

10.4.3.1.2.  Diagnostic Devices

10.4.3.1.2.1. Actigraphy systems

10.4.3.1.2.2. Polysomnography (PSG) device

10.4.3.1.2.3. Respiratory polygraphs

10.4.3.1.2.4. Pulse oximeters

10.4.3.2. Mexico Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.3.2.1.  Hospitals

10.4.3.2.2.  Sleep laboratories

10.4.3.2.3.  Home care settings

10.4.3.2.4.  Individuals

10.4.3.2.5.  Others

10.4.4. Rest of North America

10.4.4.1. Rest of North America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.4.1.1.  Therapeutic Devices

10.4.4.1.1.1. Positive Airway Pressure (PAP) device

10.4.4.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

10.4.4.1.1.1.2.    Continuous positive airway pressure (CPAP) device

10.4.4.1.1.1.3.    Automatic positive airway pressure (APAP) device

10.4.4.1.1.2. Airway clearance systems

10.4.4.1.1.3. Adaptive servo-ventilation systems

10.4.4.1.1.4. Oral appliances

10.4.4.1.1.5. Oxygen devices

10.4.4.1.1.6. Masks

10.4.4.1.1.6.1.    Full face masks

10.4.4.1.1.6.2.    Nasal masks

10.4.4.1.1.6.3.    Nasal pillows

10.4.4.1.1.6.4.    Nasal prongs

10.4.4.1.1.6.5.    Oral masks

10.4.4.1.1.7. Tubes

10.4.4.1.1.8. Humidifiers

10.4.4.1.1.9. Filters

10.4.4.1.2.  Diagnostic Devices

10.4.4.1.2.1. Actigraphy systems

10.4.4.1.2.2. Polysomnography (PSG) device

10.4.4.1.2.3. Respiratory polygraphs

10.4.4.1.2.4. Pulse oximeters

10.4.4.2. Rest of North America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.4.2.1.  Hospitals

10.4.4.2.2.  Sleep laboratories

10.4.4.2.3.  Home care settings

10.4.4.2.4.  Individuals

10.4.4.2.5.  Others

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Product

10.5.3. By End User

11. Europe Sleep Apnea Devices Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. Europe Sleep Apnea Devices Market Revenue (US$ Mn)

11.2. Europe Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.2.1. Therapeutic Devices

11.2.1.1. Positive Airway Pressure (PAP) device

11.2.1.1.1.  Bi-level positive airway pressure (BiPAP) device

11.2.1.1.2.  Continuous positive airway pressure (CPAP) device

11.2.1.1.3.  Automatic positive airway pressure (APAP) device

11.2.1.2. Airway clearance systems

11.2.1.3. Adaptive servo-ventilation systems

11.2.1.4. Oral appliances

11.2.1.5. Oxygen devices

11.2.1.6. Masks

11.2.1.6.1.  Full face masks

11.2.1.6.2.  Nasal masks

11.2.1.6.3.  Nasal pillows

11.2.1.6.4.  Nasal prongs

11.2.1.6.5.  Oral masks

11.2.1.7. Tubes

11.2.1.8. Humidifiers

11.2.1.9. Filters

11.2.2. Diagnostic Devices

11.2.2.1. Actigraphy systems

11.2.2.2. Polysomnography (PSG) device

11.2.2.3. Respiratory polygraphs

11.2.2.4. Pulse oximeters

11.3. Europe Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.3.1. Hospitals

11.3.2. Sleep laboratories

11.3.3. Home care settings

11.3.4. Individuals

11.3.5. Others

11.4. Europe Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. France

11.4.1.1. France Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.1.1.1.  Therapeutic Devices

11.4.1.1.1.1. Positive Airway Pressure (PAP) device

11.4.1.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.1.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.1.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.1.1.1.2. Airway clearance systems

11.4.1.1.1.3. Adaptive servo-ventilation systems

11.4.1.1.1.4. Oral appliances

11.4.1.1.1.5. Oxygen devices

11.4.1.1.1.6. Masks

11.4.1.1.1.6.1.    Full face masks

11.4.1.1.1.6.2.    Nasal masks

11.4.1.1.1.6.3.    Nasal pillows

11.4.1.1.1.6.4.    Nasal prongs

11.4.1.1.1.6.5.    Oral masks

11.4.1.1.1.7. Tubes

11.4.1.1.1.8. Humidifiers

11.4.1.1.1.9. Filters

11.4.1.1.2.  Diagnostic Devices

11.4.1.1.2.1. Actigraphy systems

11.4.1.1.2.2. Polysomnography (PSG) device

11.4.1.1.2.3. Respiratory polygraphs

11.4.1.1.2.4. Pulse oximeters

11.4.1.2. France Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.1.2.1.  Hospitals

11.4.1.2.2.  Sleep laboratories

11.4.1.2.3.  Home care settings

11.4.1.2.4.  Individuals

11.4.1.2.5.  Others

11.4.2. The UK

11.4.2.1. The UK Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.2.1.1.  Therapeutic Devices

11.4.2.1.1.1. Positive Airway Pressure (PAP) device

11.4.2.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.2.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.2.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.2.1.1.2. Airway clearance systems

11.4.2.1.1.3. Adaptive servo-ventilation systems

11.4.2.1.1.4. Oral appliances

11.4.2.1.1.5. Oxygen devices

11.4.2.1.1.6. Masks

11.4.2.1.1.6.1.    Full face masks

11.4.2.1.1.6.2.    Nasal masks

11.4.2.1.1.6.3.    Nasal pillows

11.4.2.1.1.6.4.    Nasal prongs

11.4.2.1.1.6.5.    Oral masks

11.4.2.1.1.7. Tubes

11.4.2.1.1.8. Humidifiers

11.4.2.1.1.9. Filters

11.4.2.1.2.  Diagnostic Devices

11.4.2.1.2.1. Actigraphy systems

11.4.2.1.2.2. Polysomnography (PSG) device

11.4.2.1.2.3. Respiratory polygraphs

11.4.2.1.2.4. Pulse oximeters

11.4.2.2. The UK Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.2.2.1.  Hospitals

11.4.2.2.2.  Sleep laboratories

11.4.2.2.3.  Home care settings

11.4.2.2.4.  Individuals

11.4.2.2.5.  Others

11.4.3. Spain

11.4.3.1. Spain Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.3.1.1.  Therapeutic Devices

11.4.3.1.1.1. Positive Airway Pressure (PAP) device

11.4.3.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.3.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.3.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.3.1.1.2. Airway clearance systems

11.4.3.1.1.3. Adaptive servo-ventilation systems

11.4.3.1.1.4. Oral appliances

11.4.3.1.1.5. Oxygen devices

11.4.3.1.1.6. Masks

11.4.3.1.1.6.1.    Full face masks

11.4.3.1.1.6.2.    Nasal masks

11.4.3.1.1.6.3.    Nasal pillows

11.4.3.1.1.6.4.    Nasal prongs

11.4.3.1.1.6.5.    Oral masks

11.4.3.1.1.7. Tubes

11.4.3.1.1.8. Humidifiers

11.4.3.1.1.9. Filters

11.4.3.1.2.  Diagnostic Devices

11.4.3.1.2.1. Actigraphy systems

11.4.3.1.2.2. Polysomnography (PSG) device

11.4.3.1.2.3. Respiratory polygraphs

11.4.3.1.2.4. Pulse oximeters

11.4.3.2. Spain Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.3.2.1.  Hospitals

11.4.3.2.2.  Sleep laboratories

11.4.3.2.3.  Home care settings

11.4.3.2.4.  Individuals

11.4.3.2.5.  Others

11.4.4. Germany

11.4.4.1. Germany Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.4.1.1.  Therapeutic Devices

11.4.4.1.1.1. Positive Airway Pressure (PAP) device

11.4.4.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.4.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.4.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.4.1.1.2. Airway clearance systems

11.4.4.1.1.3. Adaptive servo-ventilation systems

11.4.4.1.1.4. Oral appliances

11.4.4.1.1.5. Oxygen devices

11.4.4.1.1.6. Masks

11.4.4.1.1.6.1.    Full face masks

11.4.4.1.1.6.2.    Nasal masks

11.4.4.1.1.6.3.    Nasal pillows

11.4.4.1.1.6.4.    Nasal prongs

11.4.4.1.1.6.5.    Oral masks

11.4.4.1.1.7. Tubes

11.4.4.1.1.8. Humidifiers

11.4.4.1.1.9. Filters

11.4.4.1.2.  Diagnostic Devices

11.4.4.1.2.1. Actigraphy systems

11.4.4.1.2.2. Polysomnography (PSG) device

11.4.4.1.2.3. Respiratory polygraphs

11.4.4.1.2.4. Pulse oximeters

11.4.4.2. Germany Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.4.2.1.  Hospitals

11.4.4.2.2.  Sleep laboratories

11.4.4.2.3.  Home care settings

11.4.4.2.4.  Individuals

11.4.4.2.5.  Others

11.4.5. Italy

11.4.5.1. Italy Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.5.1.1.  Therapeutic Devices

11.4.5.1.1.1. Positive Airway Pressure (PAP) device

11.4.5.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.5.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.5.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.5.1.1.2. Airway clearance systems

11.4.5.1.1.3. Adaptive servo-ventilation systems

11.4.5.1.1.4. Oral appliances

11.4.5.1.1.5. Oxygen devices

11.4.5.1.1.6. Masks

11.4.5.1.1.6.1.    Full face masks

11.4.5.1.1.6.2.    Nasal masks

11.4.5.1.1.6.3.    Nasal pillows

11.4.5.1.1.6.4.    Nasal prongs

11.4.5.1.1.6.5.    Oral masks

11.4.5.1.1.7. Tubes

11.4.5.1.1.8. Humidifiers

11.4.5.1.1.9. Filters

11.4.5.1.2.  Diagnostic Devices

11.4.5.1.2.1. Actigraphy systems

11.4.5.1.2.2. Polysomnography (PSG) device

11.4.5.1.2.3. Respiratory polygraphs

11.4.5.1.2.4. Pulse oximeters

11.4.5.2. Italy Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.5.2.1.  Hospitals

11.4.5.2.2.  Sleep laboratories

11.4.5.2.3.  Home care settings

11.4.5.2.4.  Individuals

11.4.5.2.5.  Others

11.4.6. Nordic Countries

11.4.6.1. Nordic Countries Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.6.1.1.  Therapeutic Devices

11.4.6.1.1.1. Positive Airway Pressure (PAP) device

11.4.6.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.6.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.6.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.6.1.1.2. Airway clearance systems

11.4.6.1.1.3. Adaptive servo-ventilation systems

11.4.6.1.1.4. Oral appliances

11.4.6.1.1.5. Oxygen devices

11.4.6.1.1.6. Masks

11.4.6.1.1.6.1.    Full face masks

11.4.6.1.1.6.2.    Nasal masks

11.4.6.1.1.6.3.    Nasal pillows

11.4.6.1.1.6.4.    Nasal prongs

11.4.6.1.1.6.5.    Oral masks

11.4.6.1.1.7. Tubes

11.4.6.1.1.8. Humidifiers

11.4.6.1.1.9. Filters

11.4.6.1.2.  Diagnostic Devices

11.4.6.1.2.1. Actigraphy systems

11.4.6.1.2.2. Polysomnography (PSG) device

11.4.6.1.2.3. Respiratory polygraphs

11.4.6.1.2.4. Pulse oximeters

11.4.6.2. Nordic Countries Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.6.2.1.  Hospitals

11.4.6.2.2.  Sleep laboratories

11.4.6.2.3.  Home care settings

11.4.6.2.4.  Individuals

11.4.6.2.5.  Others

11.4.6.3. Nordic Countries Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

11.4.6.3.1.  Denmark

11.4.6.3.2.  Finland

11.4.6.3.3.  Iceland

11.4.6.3.4.  Sweden

11.4.6.3.5.  Norway

11.4.7. Benelux Union

11.4.7.1. Benelux Union Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.7.1.1.  Therapeutic Devices

11.4.7.1.1.1. Positive Airway Pressure (PAP) device

11.4.7.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.7.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.7.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.7.1.1.2. Airway clearance systems

11.4.7.1.1.3. Adaptive servo-ventilation systems

11.4.7.1.1.4. Oral appliances

11.4.7.1.1.5. Oxygen devices

11.4.7.1.1.6. Masks

11.4.7.1.1.6.1.    Full face masks

11.4.7.1.1.6.2.    Nasal masks

11.4.7.1.1.6.3.    Nasal pillows

11.4.7.1.1.6.4.    Nasal prongs

11.4.7.1.1.6.5.    Oral masks

11.4.7.1.1.7. Tubes

11.4.7.1.1.8. Humidifiers

11.4.7.1.1.9. Filters

11.4.7.1.2.  Diagnostic Devices

11.4.7.1.2.1. Actigraphy systems

11.4.7.1.2.2. Polysomnography (PSG) device

11.4.7.1.2.3. Respiratory polygraphs

11.4.7.1.2.4. Pulse oximeters

11.4.7.2. Benelux Union Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.7.2.1.  Hospitals

11.4.7.2.2.  Sleep laboratories

11.4.7.2.3.  Home care settings

11.4.7.2.4.  Individuals

11.4.7.2.5.  Others

11.4.7.3. Benelux Union Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

11.4.7.3.1.  Belgium

11.4.7.3.2.  The Netherlands

11.4.7.3.3.  Luxembourg

11.4.8. Rest of Europe

11.4.8.1. Rest of Europe Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.8.1.1.  Therapeutic Devices

11.4.8.1.1.1. Positive Airway Pressure (PAP) device

11.4.8.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

11.4.8.1.1.1.2.    Continuous positive airway pressure (CPAP) device

11.4.8.1.1.1.3.    Automatic positive airway pressure (APAP) device

11.4.8.1.1.2. Airway clearance systems

11.4.8.1.1.3. Adaptive servo-ventilation systems

11.4.8.1.1.4. Oral appliances

11.4.8.1.1.5. Oxygen devices

11.4.8.1.1.6. Masks

11.4.8.1.1.6.1.    Full face masks

11.4.8.1.1.6.2.    Nasal masks

11.4.8.1.1.6.3.    Nasal pillows

11.4.8.1.1.6.4.    Nasal prongs

11.4.8.1.1.6.5.    Oral masks

11.4.8.1.1.7. Tubes

11.4.8.1.1.8. Humidifiers

11.4.8.1.1.9. Filters

11.4.8.1.2.  Diagnostic Devices

11.4.8.1.2.1. Actigraphy systems

11.4.8.1.2.2. Polysomnography (PSG) device

11.4.8.1.2.3. Respiratory polygraphs

11.4.8.1.2.4. Pulse oximeters

11.4.8.2. Rest of Europe Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.8.2.1.  Hospitals

11.4.8.2.2.  Sleep laboratories

11.4.8.2.3.  Home care settings

11.4.8.2.4.  Individuals

11.4.8.2.5.  Others

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Product

11.5.3. By End User

12. Asia Pacific Sleep Apnea Devices Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn)

12.2. Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.2.1. Therapeutic Devices

12.2.1.1. Positive Airway Pressure (PAP) device

12.2.1.1.1.  Bi-level positive airway pressure (BiPAP) device

12.2.1.1.2.  Continuous positive airway pressure (CPAP) device

12.2.1.1.3.  Automatic positive airway pressure (APAP) device

12.2.1.2. Airway clearance systems

12.2.1.3. Adaptive servo-ventilation systems

12.2.1.4. Oral appliances

12.2.1.5. Oxygen devices

12.2.1.6. Masks

12.2.1.6.1.  Full face masks

12.2.1.6.2.  Nasal masks

12.2.1.6.3.  Nasal pillows

12.2.1.6.4.  Nasal prongs

12.2.1.6.5.  Oral masks

12.2.1.7. Tubes

12.2.1.8. Humidifiers

12.2.1.9. Filters

12.2.2. Diagnostic Devices

12.2.2.1. Actigraphy systems

12.2.2.2. Polysomnography (PSG) device

12.2.2.3. Respiratory polygraphs

12.2.2.4. Pulse oximeters

12.3. Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.3.1. Hospitals

12.3.2. Sleep laboratories

12.3.3. Home care settings

12.3.4. Individuals

12.3.5. Others

12.4. Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

12.4.1. China

12.4.1.1. China Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.1.1.1.  Therapeutic Devices

12.4.1.1.1.1. Positive Airway Pressure (PAP) device

12.4.1.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.1.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.1.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.1.1.1.2. Airway clearance systems

12.4.1.1.1.3. Adaptive servo-ventilation systems

12.4.1.1.1.4. Oral appliances

12.4.1.1.1.5. Oxygen devices

12.4.1.1.1.6. Masks

12.4.1.1.1.6.1.    Full face masks

12.4.1.1.1.6.2.    Nasal masks

12.4.1.1.1.6.3.    Nasal pillows

12.4.1.1.1.6.4.    Nasal prongs

12.4.1.1.1.6.5.    Oral masks

12.4.1.1.1.7. Tubes

12.4.1.1.1.8. Humidifiers

12.4.1.1.1.9. Filters

12.4.1.1.2.  Diagnostic Devices

12.4.1.1.2.1. Actigraphy systems

12.4.1.1.2.2. Polysomnography (PSG) device

12.4.1.1.2.3. Respiratory polygraphs

12.4.1.1.2.4. Pulse oximeters

12.4.1.2. China Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.1.2.1.  Hospitals

12.4.1.2.2.  Sleep laboratories

12.4.1.2.3.  Home care settings

12.4.1.2.4.  Individuals

12.4.1.2.5.  Others

12.4.2. Japan

12.4.2.1. Japan Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.2.1.1.  Therapeutic Devices

12.4.2.1.1.1. Positive Airway Pressure (PAP) device

12.4.2.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.2.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.2.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.2.1.1.2. Airway clearance systems

12.4.2.1.1.3. Adaptive servo-ventilation systems

12.4.2.1.1.4. Oral appliances

12.4.2.1.1.5. Oxygen devices

12.4.2.1.1.6. Masks

12.4.2.1.1.6.1.    Full face masks

12.4.2.1.1.6.2.    Nasal masks

12.4.2.1.1.6.3.    Nasal pillows

12.4.2.1.1.6.4.    Nasal prongs

12.4.2.1.1.6.5.    Oral masks

12.4.2.1.1.7. Tubes

12.4.2.1.1.8. Humidifiers

12.4.2.1.1.9. Filters

12.4.2.1.2.  Diagnostic Devices

12.4.2.1.2.1. Actigraphy systems

12.4.2.1.2.2. Polysomnography (PSG) device

12.4.2.1.2.3. Respiratory polygraphs

12.4.2.1.2.4. Pulse oximeters

12.4.2.2. Japan Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.2.2.1.  Hospitals

12.4.2.2.2.  Sleep laboratories

12.4.2.2.3.  Home care settings

12.4.2.2.4.  Individuals

12.4.2.2.5.  Others

12.4.3. India

12.4.3.1. India Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.3.1.1.  Therapeutic Devices

12.4.3.1.1.1. Positive Airway Pressure (PAP) device

12.4.3.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.3.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.3.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.3.1.1.2. Airway clearance systems

12.4.3.1.1.3. Adaptive servo-ventilation systems

12.4.3.1.1.4. Oral appliances

12.4.3.1.1.5. Oxygen devices

12.4.3.1.1.6. Masks

12.4.3.1.1.6.1.    Full face masks

12.4.3.1.1.6.2.    Nasal masks

12.4.3.1.1.6.3.    Nasal pillows

12.4.3.1.1.6.4.    Nasal prongs

12.4.3.1.1.6.5.    Oral masks

12.4.3.1.1.7. Tubes

12.4.3.1.1.8. Humidifiers

12.4.3.1.1.9. Filters

12.4.3.1.2.  Diagnostic Devices

12.4.3.1.2.1. Actigraphy systems

12.4.3.1.2.2. Polysomnography (PSG) device

12.4.3.1.2.3. Respiratory polygraphs

12.4.3.1.2.4. Pulse oximeters

12.4.3.2. India Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.3.2.1.  Hospitals

12.4.3.2.2.  Sleep laboratories

12.4.3.2.3.  Home care settings

12.4.3.2.4.  Individuals

12.4.3.2.5.  Others

12.4.4. New Zealand

12.4.4.1. New Zealand Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.4.1.1.  Therapeutic Devices

12.4.4.1.1.1. Positive Airway Pressure (PAP) device

12.4.4.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.4.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.4.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.4.1.1.2. Airway clearance systems

12.4.4.1.1.3. Adaptive servo-ventilation systems

12.4.4.1.1.4. Oral appliances

12.4.4.1.1.5. Oxygen devices

12.4.4.1.1.6. Masks

12.4.4.1.1.6.1.    Full face masks

12.4.4.1.1.6.2.    Nasal masks

12.4.4.1.1.6.3.    Nasal pillows

12.4.4.1.1.6.4.    Nasal prongs

12.4.4.1.1.6.5.    Oral masks

12.4.4.1.1.7. Tubes

12.4.4.1.1.8. Humidifiers

12.4.4.1.1.9. Filters

12.4.4.1.2.  Diagnostic Devices

12.4.4.1.2.1. Actigraphy systems

12.4.4.1.2.2. Polysomnography (PSG) device

12.4.4.1.2.3. Respiratory polygraphs

12.4.4.1.2.4. Pulse oximeters

12.4.4.2. New Zealand Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.4.2.1.  Hospitals

12.4.4.2.2.  Sleep laboratories

12.4.4.2.3.  Home care settings

12.4.4.2.4.  Individuals

12.4.4.2.5.  Others

12.4.5. Australia

12.4.5.1. Australia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.5.1.1.  Therapeutic Devices

12.4.5.1.1.1. Positive Airway Pressure (PAP) device

12.4.5.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.5.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.5.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.5.1.1.2. Airway clearance systems

12.4.5.1.1.3. Adaptive servo-ventilation systems

12.4.5.1.1.4. Oral appliances

12.4.5.1.1.5. Oxygen devices

12.4.5.1.1.6. Masks

12.4.5.1.1.6.1.    Full face masks

12.4.5.1.1.6.2.    Nasal masks

12.4.5.1.1.6.3.    Nasal pillows

12.4.5.1.1.6.4.    Nasal prongs

12.4.5.1.1.6.5.    Oral masks

12.4.5.1.1.7. Tubes

12.4.5.1.1.8. Humidifiers

12.4.5.1.1.9. Filters

12.4.5.1.2.  Diagnostic Devices

12.4.5.1.2.1. Actigraphy systems

12.4.5.1.2.2. Polysomnography (PSG) device

12.4.5.1.2.3. Respiratory polygraphs

12.4.5.1.2.4. Pulse oximeters

12.4.5.2. Australia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.5.2.1.  Hospitals

12.4.5.2.2.  Sleep laboratories

12.4.5.2.3.  Home care settings

12.4.5.2.4.  Individuals

12.4.5.2.5.  Others

12.4.6. South Korea

12.4.6.1. South Korea Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.6.1.1.  Therapeutic Devices

12.4.6.1.1.1. Positive Airway Pressure (PAP) device

12.4.6.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.6.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.6.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.6.1.1.2. Airway clearance systems

12.4.6.1.1.3. Adaptive servo-ventilation systems

12.4.6.1.1.4. Oral appliances

12.4.6.1.1.5. Oxygen devices

12.4.6.1.1.6. Masks

12.4.6.1.1.6.1.    Full face masks

12.4.6.1.1.6.2.    Nasal masks

12.4.6.1.1.6.3.    Nasal pillows

12.4.6.1.1.6.4.    Nasal prongs

12.4.6.1.1.6.5.    Oral masks

12.4.6.1.1.7. Tubes

12.4.6.1.1.8. Humidifiers

12.4.6.1.1.9. Filters

12.4.6.1.2.  Diagnostic Devices

12.4.6.1.2.1. Actigraphy systems

12.4.6.1.2.2. Polysomnography (PSG) device

12.4.6.1.2.3. Respiratory polygraphs

12.4.6.1.2.4. Pulse oximeters

12.4.6.2. South Korea Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.6.2.1.  Hospitals

12.4.6.2.2.  Sleep laboratories

12.4.6.2.3.  Home care settings

12.4.6.2.4.  Individuals

12.4.6.2.5.  Others

12.4.7. Southeast Asia

12.4.7.1. Southeast Asia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.7.1.1.  Therapeutic Devices

12.4.7.1.1.1. Positive Airway Pressure (PAP) device

12.4.7.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.7.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.7.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.7.1.1.2. Airway clearance systems

12.4.7.1.1.3. Adaptive servo-ventilation systems

12.4.7.1.1.4. Oral appliances

12.4.7.1.1.5. Oxygen devices

12.4.7.1.1.6. Masks

12.4.7.1.1.6.1.    Full face masks

12.4.7.1.1.6.2.    Nasal masks

12.4.7.1.1.6.3.    Nasal pillows

12.4.7.1.1.6.4.    Nasal prongs

12.4.7.1.1.6.5.    Oral masks

12.4.7.1.1.7. Tubes

12.4.7.1.1.8. Humidifiers

12.4.7.1.1.9. Filters

12.4.7.1.2.  Diagnostic Devices

12.4.7.1.2.1. Actigraphy systems

12.4.7.1.2.2. Polysomnography (PSG) device

12.4.7.1.2.3. Respiratory polygraphs

12.4.7.1.2.4. Pulse oximeters

12.4.7.2. Southeast Asia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.7.2.1.  Hospitals

12.4.7.2.2.  Sleep laboratories

12.4.7.2.3.  Home care settings

12.4.7.2.4.  Individuals

12.4.7.2.5.  Others

12.4.7.3. Southeast Asia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

12.4.7.3.1.  Indonesia

12.4.7.3.2.  Thailand

12.4.7.3.3.  Malaysia

12.4.7.3.4.  Singapore

12.4.7.3.5.  Rest of Southeast Asia

12.4.8. Rest of Asia Pacific

12.4.8.1. Rest of Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

12.4.8.1.1.  Therapeutic Devices

12.4.8.1.1.1. Positive Airway Pressure (PAP) device

12.4.8.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

12.4.8.1.1.1.2.    Continuous positive airway pressure (CPAP) device

12.4.8.1.1.1.3.    Automatic positive airway pressure (APAP) device

12.4.8.1.1.2. Airway clearance systems

12.4.8.1.1.3. Adaptive servo-ventilation systems

12.4.8.1.1.4. Oral appliances

12.4.8.1.1.5. Oxygen devices

12.4.8.1.1.6. Masks

12.4.8.1.1.6.1.    Full face masks

12.4.8.1.1.6.2.    Nasal masks

12.4.8.1.1.6.3.    Nasal pillows

12.4.8.1.1.6.4.    Nasal prongs

12.4.8.1.1.6.5.    Oral masks

12.4.8.1.1.7. Tubes

12.4.8.1.1.8. Humidifiers

12.4.8.1.1.9. Filters

12.4.8.1.2.  Diagnostic Devices

12.4.8.1.2.1. Actigraphy systems

12.4.8.1.2.2. Polysomnography (PSG) device

12.4.8.1.2.3. Respiratory polygraphs

12.4.8.1.2.4. Pulse oximeters

12.4.8.2. Rest of Asia Pacific Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

12.4.8.2.1.  Hospitals

12.4.8.2.2.  Sleep laboratories

12.4.8.2.3.  Home care settings

12.4.8.2.4.  Individuals

12.4.8.2.5.  Others

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Product

12.5.3. By End User

13. Middle East and Africa Sleep Apnea Devices Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn)

13.2. Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.2.1. Therapeutic Devices

13.2.1.1. Positive Airway Pressure (PAP) device

13.2.1.1.1.  Bi-level positive airway pressure (BiPAP) device

13.2.1.1.2.  Continuous positive airway pressure (CPAP) device

13.2.1.1.3.  Automatic positive airway pressure (APAP) device

13.2.1.2. Airway clearance systems

13.2.1.3. Adaptive servo-ventilation systems

13.2.1.4. Oral appliances

13.2.1.5. Oxygen devices

13.2.1.6. Masks

13.2.1.6.1.  Full face masks

13.2.1.6.2.  Nasal masks

13.2.1.6.3.  Nasal pillows

13.2.1.6.4.  Nasal prongs

13.2.1.6.5.  Oral masks

13.2.1.7. Tubes

13.2.1.8. Humidifiers

13.2.1.9. Filters

13.2.2. Diagnostic Devices

13.2.2.1. Actigraphy systems

13.2.2.2. Polysomnography (PSG) device

13.2.2.3. Respiratory polygraphs

13.2.2.4. Pulse oximeters

13.3. Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.3.1. Hospitals

13.3.2. Sleep laboratories

13.3.3. Home care settings

13.3.4. Individuals

13.3.5. Others

13.4. Middle East and Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

13.4.1. Saudi Arabia

13.4.1.1. Saudi Arabia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.4.1.1.1.  Therapeutic Devices

13.4.1.1.1.1. Positive Airway Pressure (PAP) device

13.4.1.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

13.4.1.1.1.1.2.    Continuous positive airway pressure (CPAP) device

13.4.1.1.1.1.3.    Automatic positive airway pressure (APAP) device

13.4.1.1.1.2. Airway clearance systems

13.4.1.1.1.3. Adaptive servo-ventilation systems

13.4.1.1.1.4. Oral appliances

13.4.1.1.1.5. Oxygen devices

13.4.1.1.1.6. Masks

13.4.1.1.1.6.1.    Full face masks

13.4.1.1.1.6.2.    Nasal masks

13.4.1.1.1.6.3.    Nasal pillows

13.4.1.1.1.6.4.    Nasal prongs

13.4.1.1.1.6.5.    Oral masks

13.4.1.1.1.7. Tubes

13.4.1.1.1.8. Humidifiers

13.4.1.1.1.9. Filters

13.4.1.1.2.  Diagnostic Devices

13.4.1.1.2.1. Actigraphy systems

13.4.1.1.2.2. Polysomnography (PSG) device

13.4.1.1.2.3. Respiratory polygraphs

13.4.1.1.2.4. Pulse oximeters

13.4.1.2. Saudi Arabia Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.4.1.2.1.  Hospitals

13.4.1.2.2.  Sleep laboratories

13.4.1.2.3.  Home care settings

13.4.1.2.4.  Individuals

13.4.1.2.5.  Others

13.4.2. UAE

13.4.2.1. UAE Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.4.2.1.1.  Therapeutic Devices

13.4.2.1.1.1. Positive Airway Pressure (PAP) device

13.4.2.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

13.4.2.1.1.1.2.    Continuous positive airway pressure (CPAP) device

13.4.2.1.1.1.3.    Automatic positive airway pressure (APAP) device

13.4.2.1.1.2. Airway clearance systems

13.4.2.1.1.3. Adaptive servo-ventilation systems

13.4.2.1.1.4. Oral appliances

13.4.2.1.1.5. Oxygen devices

13.4.2.1.1.6. Masks

13.4.2.1.1.6.1.    Full face masks

13.4.2.1.1.6.2.    Nasal masks

13.4.2.1.1.6.3.    Nasal pillows

13.4.2.1.1.6.4.    Nasal prongs

13.4.2.1.1.6.5.    Oral masks

13.4.2.1.1.7. Tubes

13.4.2.1.1.8. Humidifiers

13.4.2.1.1.9. Filters

13.4.2.1.2.  Diagnostic Devices

13.4.2.1.2.1. Actigraphy systems

13.4.2.1.2.2. Polysomnography (PSG) device

13.4.2.1.2.3. Respiratory polygraphs

13.4.2.1.2.4. Pulse oximeters

13.4.2.2. UAE Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.4.2.2.1.  Hospitals

13.4.2.2.2.  Sleep laboratories

13.4.2.2.3.  Home care settings

13.4.2.2.4.  Individuals

13.4.2.2.5.  Others

13.4.3. Egypt

13.4.3.1. Egypt Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.4.3.1.1.  Therapeutic Devices

13.4.3.1.1.1. Positive Airway Pressure (PAP) device

13.4.3.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

13.4.3.1.1.1.2.    Continuous positive airway pressure (CPAP) device

13.4.3.1.1.1.3.    Automatic positive airway pressure (APAP) device

13.4.3.1.1.2. Airway clearance systems

13.4.3.1.1.3. Adaptive servo-ventilation systems

13.4.3.1.1.4. Oral appliances

13.4.3.1.1.5. Oxygen devices

13.4.3.1.1.6. Masks

13.4.3.1.1.6.1.    Full face masks

13.4.3.1.1.6.2.    Nasal masks

13.4.3.1.1.6.3.    Nasal pillows

13.4.3.1.1.6.4.    Nasal prongs

13.4.3.1.1.6.5.    Oral masks

13.4.3.1.1.7. Tubes

13.4.3.1.1.8. Humidifiers

13.4.3.1.1.9. Filters

13.4.3.1.2.  Diagnostic Devices

13.4.3.1.2.1. Actigraphy systems

13.4.3.1.2.2. Polysomnography (PSG) device

13.4.3.1.2.3. Respiratory polygraphs

13.4.3.1.2.4. Pulse oximeters

13.4.3.2. Egypt Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.4.3.2.1.  Hospitals

13.4.3.2.2.  Sleep laboratories

13.4.3.2.3.  Home care settings

13.4.3.2.4.  Individuals

13.4.3.2.5.  Others

13.4.4. Kuwait

13.4.4.1. Kuwait Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.4.4.1.1.  Therapeutic Devices

13.4.4.1.1.1. Positive Airway Pressure (PAP) device

13.4.4.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

13.4.4.1.1.1.2.    Continuous positive airway pressure (CPAP) device

13.4.4.1.1.1.3.    Automatic positive airway pressure (APAP) device

13.4.4.1.1.2. Airway clearance systems

13.4.4.1.1.3. Adaptive servo-ventilation systems

13.4.4.1.1.4. Oral appliances

13.4.4.1.1.5. Oxygen devices

13.4.4.1.1.6. Masks

13.4.4.1.1.6.1.    Full face masks

13.4.4.1.1.6.2.    Nasal masks

13.4.4.1.1.6.3.    Nasal pillows

13.4.4.1.1.6.4.    Nasal prongs

13.4.4.1.1.6.5.    Oral masks

13.4.4.1.1.7. Tubes

13.4.4.1.1.8. Humidifiers

13.4.4.1.1.9. Filters

13.4.4.1.2.  Diagnostic Devices

13.4.4.1.2.1. Actigraphy systems

13.4.4.1.2.2. Polysomnography (PSG) device

13.4.4.1.2.3. Respiratory polygraphs

13.4.4.1.2.4. Pulse oximeters

13.4.4.2. Kuwait Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.4.4.2.1.  Hospitals

13.4.4.2.2.  Sleep laboratories

13.4.4.2.3.  Home care settings

13.4.4.2.4.  Individuals

13.4.4.2.5.  Others

13.4.5. South Africa

13.4.5.1. South Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.4.5.1.1.  Therapeutic Devices

13.4.5.1.1.1. Positive Airway Pressure (PAP) device

13.4.5.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

13.4.5.1.1.1.2.    Continuous positive airway pressure (CPAP) device

13.4.5.1.1.1.3.    Automatic positive airway pressure (APAP) device

13.4.5.1.1.2. Airway clearance systems

13.4.5.1.1.3. Adaptive servo-ventilation systems

13.4.5.1.1.4. Oral appliances

13.4.5.1.1.5. Oxygen devices

13.4.5.1.1.6. Masks

13.4.5.1.1.6.1.    Full face masks

13.4.5.1.1.6.2.    Nasal masks

13.4.5.1.1.6.3.    Nasal pillows

13.4.5.1.1.6.4.    Nasal prongs

13.4.5.1.1.6.5.    Oral masks

13.4.5.1.1.7. Tubes

13.4.5.1.1.8. Humidifiers

13.4.5.1.1.9. Filters

13.4.5.1.2.  Diagnostic Devices

13.4.5.1.2.1. Actigraphy systems

13.4.5.1.2.2. Polysomnography (PSG) device

13.4.5.1.2.3. Respiratory polygraphs

13.4.5.1.2.4. Pulse oximeters

13.4.5.2. South Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.4.5.2.1.  Hospitals

13.4.5.2.2.  Sleep laboratories

13.4.5.2.3.  Home care settings

13.4.5.2.4.  Individuals

13.4.5.2.5.  Others

13.4.6. Rest of Middle East & Africa

13.4.6.1. Rest of Middle East & Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

13.4.6.1.1.  Therapeutic Devices

13.4.6.1.1.1. Positive Airway Pressure (PAP) device

13.4.6.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

13.4.6.1.1.1.2.    Continuous positive airway pressure (CPAP) device

13.4.6.1.1.1.3.    Automatic positive airway pressure (APAP) device

13.4.6.1.1.2. Airway clearance systems

13.4.6.1.1.3. Adaptive servo-ventilation systems

13.4.6.1.1.4. Oral appliances

13.4.6.1.1.5. Oxygen devices

13.4.6.1.1.6. Masks

13.4.6.1.1.6.1.    Full face masks

13.4.6.1.1.6.2.    Nasal masks

13.4.6.1.1.6.3.    Nasal pillows

13.4.6.1.1.6.4.    Nasal prongs

13.4.6.1.1.6.5.    Oral masks

13.4.6.1.1.7. Tubes

13.4.6.1.1.8. Humidifiers

13.4.6.1.1.9. Filters

13.4.6.1.2.  Diagnostic Devices

13.4.6.1.2.1. Actigraphy systems

13.4.6.1.2.2. Polysomnography (PSG) device

13.4.6.1.2.3. Respiratory polygraphs

13.4.6.1.2.4. Pulse oximeters

13.4.6.2. Rest of Middle East & Africa Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

13.4.6.2.1.  Hospitals

13.4.6.2.2.  Sleep laboratories

13.4.6.2.3.  Home care settings

13.4.6.2.4.  Individuals

13.4.6.2.5.  Others

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Product

13.5.3. By End User

14. Latin America Sleep Apnea Devices Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Latin America Sleep Apnea Devices Market Revenue (US$ Mn)

14.2. Latin America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

14.2.1. Therapeutic Devices

14.2.1.1. Positive Airway Pressure (PAP) device

14.2.1.1.1.  Bi-level positive airway pressure (BiPAP) device

14.2.1.1.2.  Continuous positive airway pressure (CPAP) device

14.2.1.1.3.  Automatic positive airway pressure (APAP) device

14.2.1.2. Airway clearance systems

14.2.1.3. Adaptive servo-ventilation systems

14.2.1.4. Oral appliances

14.2.1.5. Oxygen devices

14.2.1.6. Masks

14.2.1.6.1.  Full face masks

14.2.1.6.2.  Nasal masks

14.2.1.6.3.  Nasal pillows

14.2.1.6.4.  Nasal prongs

14.2.1.6.5.  Oral masks

14.2.1.7. Tubes

14.2.1.8. Humidifiers

14.2.1.9. Filters

14.2.2. Diagnostic Devices

14.2.2.1. Actigraphy systems

14.2.2.2. Polysomnography (PSG) device

14.2.2.3. Respiratory polygraphs

14.2.2.4. Pulse oximeters

14.3. Latin America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

14.3.1. Hospitals

14.3.2. Sleep laboratories

14.3.3. Home care settings

14.3.4. Individuals

14.3.5. Others

14.4. Latin America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

14.4.1.1.1.  Therapeutic Devices

14.4.1.1.1.1. Positive Airway Pressure (PAP) device

14.4.1.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

14.4.1.1.1.1.2.    Continuous positive airway pressure (CPAP) device

14.4.1.1.1.1.3.    Automatic positive airway pressure (APAP) device

14.4.1.1.1.2. Airway clearance systems

14.4.1.1.1.3. Adaptive servo-ventilation systems

14.4.1.1.1.4. Oral appliances

14.4.1.1.1.5. Oxygen devices

14.4.1.1.1.6. Masks

14.4.1.1.1.6.1.    Full face masks

14.4.1.1.1.6.2.    Nasal masks

14.4.1.1.1.6.3.    Nasal pillows

14.4.1.1.1.6.4.    Nasal prongs

14.4.1.1.1.6.5.    Oral masks

14.4.1.1.1.7. Tubes

14.4.1.1.1.8. Humidifiers

14.4.1.1.1.9. Filters

14.4.1.1.2.  Diagnostic Devices

14.4.1.1.2.1. Actigraphy systems

14.4.1.1.2.2. Polysomnography (PSG) device

14.4.1.1.2.3. Respiratory polygraphs

14.4.1.1.2.4. Pulse oximeters

14.4.1.2. Brazil Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

14.4.1.2.1.  Hospitals

14.4.1.2.2.  Sleep laboratories

14.4.1.2.3.  Home care settings

14.4.1.2.4.  Individuals

14.4.1.2.5.  Others

14.4.2. Argentina

14.4.2.1. Argentina Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

14.4.2.1.1.  Therapeutic Devices

14.4.2.1.1.1. Positive Airway Pressure (PAP) device

14.4.2.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

14.4.2.1.1.1.2.    Continuous positive airway pressure (CPAP) device

14.4.2.1.1.1.3.    Automatic positive airway pressure (APAP) device

14.4.2.1.1.2. Airway clearance systems

14.4.2.1.1.3. Adaptive servo-ventilation systems

14.4.2.1.1.4. Oral appliances

14.4.2.1.1.5. Oxygen devices

14.4.2.1.1.6. Masks

14.4.2.1.1.6.1.    Full face masks

14.4.2.1.1.6.2.    Nasal masks

14.4.2.1.1.6.3.    Nasal pillows

14.4.2.1.1.6.4.    Nasal prongs

14.4.2.1.1.6.5.    Oral masks

14.4.2.1.1.7. Tubes

14.4.2.1.1.8. Humidifiers

14.4.2.1.1.9. Filters

14.4.2.1.2.  Diagnostic Devices

14.4.2.1.2.1. Actigraphy systems

14.4.2.1.2.2. Polysomnography (PSG) device

14.4.2.1.2.3. Respiratory polygraphs

14.4.2.1.2.4. Pulse oximeters

14.4.2.2. Argentina Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

14.4.2.2.1.  Hospitals

14.4.2.2.2.  Sleep laboratories

14.4.2.2.3.  Home care settings

14.4.2.2.4.  Individuals

14.4.2.2.5.  Others

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By Product

14.4.3.1.1.  Therapeutic Devices

14.4.3.1.1.1. Positive Airway Pressure (PAP) device

14.4.3.1.1.1.1.    Bi-level positive airway pressure (BiPAP) device

14.4.3.1.1.1.2.    Continuous positive airway pressure (CPAP) device

14.4.3.1.1.1.3.    Automatic positive airway pressure (APAP) device

14.4.3.1.1.2. Airway clearance systems

14.4.3.1.1.3. Adaptive servo-ventilation systems

14.4.3.1.1.4. Oral appliances

14.4.3.1.1.5. Oxygen devices

14.4.3.1.1.6. Masks

14.4.3.1.1.6.1.    Full face masks

14.4.3.1.1.6.2.    Nasal masks

14.4.3.1.1.6.3.    Nasal pillows

14.4.3.1.1.6.4.    Nasal prongs

14.4.3.1.1.6.5.    Oral masks

14.4.3.1.1.7. Tubes

14.4.3.1.1.8. Humidifiers

14.4.3.1.1.9. Filters

14.4.3.1.2.  Diagnostic Devices

14.4.3.1.2.1. Actigraphy systems

14.4.3.1.2.2. Polysomnography (PSG) device

14.4.3.1.2.3. Respiratory polygraphs

14.4.3.1.2.4. Pulse oximeters

14.4.3.2. Rest of Latin America Sleep Apnea Devices Market Revenue (US$ Mn) and Forecasts, By End User

14.4.3.2.1.  Hospitals

14.4.3.2.2.  Sleep laboratories

14.4.3.2.3.  Home care settings

14.4.3.2.4.  Individuals

14.4.3.2.5.  Others

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Product

14.5.3. By End User

15. Competitive Benchmarking

15.1. Brand Benchmarking

15.2. Market Share Analysis, 2018

15.3. Global Presence and Growth Strategies

15.3.1. Mergers and Acquisitions

15.3.2. Product Launches

15.3.3. Investments Trends

15.3.4. R&D Initiatives

16. Player Profiles

16.1. BMC Medical Co., Ltd.

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. Becton Dickinson (CareFusion Corporation)

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Braebon Medical Corporation

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. ResMed, Inc.

16.4.1. Company Details

16.4.2. Company Overview

16.4.3. Product Offerings

16.4.4. Key Developments

16.4.5. Financial Analysis

16.4.6. SWOT Analysis

16.4.7. Business Strategies

16.5. Teleflex, Inc.

16.5.1. Company Details

16.5.2. Company Overview

16.5.3. Product Offerings

16.5.4. Key Developments

16.5.5. Financial Analysis

16.5.6. SWOT Analysis

16.5.7. Business Strategies

16.6. ImThera Medical Inc.

16.6.1. Company Details

16.6.2. Company Overview

16.6.3. Product Offerings

16.6.4. Key Developments

16.6.5. Financial Analysis

16.6.6. SWOT Analysis

16.6.7. Business Strategies

16.7. Nihon Kohden

16.7.1. Company Details

16.7.2. Company Overview

16.7.3. Product Offerings

16.7.4. Key Developments

16.7.5. Financial Analysis

16.7.6. SWOT Analysis

16.7.7. Business Strategies

16.8. Cadwell Laboratories

16.8.1. Company Details

16.8.2. Company Overview

16.8.3. Product Offerings

16.8.4. Key Developments

16.8.5. Financial Analysis

16.8.6. SWOT Analysis

16.8.7. Business Strategies

16.9. Invacare Corporation

16.9.1. Company Details

16.9.2. Company Overview

16.9.3. Product Offerings

16.9.4. Key Developments

16.9.5. Financial Analysis

16.9.6. SWOT Analysis

16.9.7. Business Strategies

16.10. Phillips Respironics

16.10.1. Company Details

16.10.2. Company Overview

16.10.3. Product Offerings

16.10.4. Key Developments

16.10.5. Financial Analysis

16.10.6. SWOT Analysis

16.10.7. Business Strategies

16.11. Compumedics Limited

16.11.1. Company Details

16.11.2. Company Overview

16.11.3. Product Offerings

16.11.4. Key Developments

16.11.5. Financial Analysis

16.11.6. SWOT Analysis

16.11.7. Business Strategies

16.12. Fisher & Paykel Healthcare

16.12.1. Company Details

16.12.2. Company Overview

16.12.3. Product Offerings

16.12.4. Key Developments

16.12.5. Financial Analysis

16.12.6. SWOT Analysis

16.12.7. Business Strategies

16.13. Other industry participants

17. Key Findings: Organic Sugar Market

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once